Evidence map›Paper›PMID 27980614›Full record

ArticleBMC proceedings2016

Omics-squared: human genomic, transcriptomic and phenotypic data for genetic analysis workshop 19.

John Blangero, Tanya M Teslovich, Xueling Sim, Marcio A Almeida, Goo Jun, Thomas D Dyer, Matthew Johnson, Juan M Peralta, Alisa Manning, Andrew R Wood and 24 more

Open access · goldAbstract read
In one paragraph

Article in BMC proceedings, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Advances in the Genetics of Hypertension: The Effect of Rare Variants.International journal of molecular sciences · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Pathway-based analyses.BMC genetics · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 12 institutions in 4 countries.

John BlangeroSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Tanya M TeslovichDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Xueling SimDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Marcio A AlmeidaSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Goo JunDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA ; Department of Epidemiology, Human Genetics and Environmenal Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030 USA.
Thomas D DyerSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Matthew JohnsonSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Juan M PeraltaSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Alisa ManningDepartment of Genetics, Massachusetts General Hospital, Boston, MA 02114 USA.
Andrew R WoodGenetics of Complex Traits, Peninsula College of Medicine and Dentistry, University of Exeter, Exeter, UK.
Christian FuchsbergerDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Jack W KentDepartment of Genetics, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
David A AguilarCardiovascular Division, Baylor College of Medicine, Houston, TX 77030 USA.
Jennifer E BelowDepartment of Epidemiology, Human Genetics and Environmenal Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030 USA.
Vidya S FarookSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Rector AryaSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Sharon FowlerDivision of Clinical Epidemiology, Department of Medicine, University of San Antonio Health Science Center at San Antonio, San Antonio, TX 78229 USA.
Tom W BlackwellDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Sobha PuppalaDepartment of Genetics, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
Satish KumarSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
David C GlahnDepartment of Psychiatry, Yale University, New Haven, CT 06106 USA.
Eric K MosesCentre for Genetic Origins of Health and Disease, University of Western Australia, Crawley, Australia.
Joanne E CurranSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Farook ThameemDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Safat, Kuwait City, 13110 Kuwait.
Christopher P JenkinsonSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Ralph A DeFronzoTexas Diabetes Institute, University of San Antonio Health Science Center at San Antonio, San Antonio, TX 78229 USA.
Donna M LehmanDivision of Clinical Epidemiology, Department of Medicine, University of San Antonio Health Science Center at San Antonio, San Antonio, TX 78229 USA.
Craig HanisDepartment of Epidemiology, Human Genetics and Environmenal Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030 USA.
Goncalo AbecasisDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Michael BoehnkeDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109 USA.
Harald GöringSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Ravindranath DuggiralaSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA.
Laura AlmasySouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Harlingen, TX 78550 USA ; Department of Genetics, University of Pennsylvania, Philadelphia, PA 19104 USA.
T2D-GENES Consortium
The University of Texas Rio Grande Valley · USUniversity of Michigan–Ann Arbor · USThe University of Texas Health Science Center at San Antonio · USTexas Biomedical Research Institute · USThe University of Texas Health Science Center at Houston · USBaylor College of Medicine · USCalifornia University of Pennsylvania · USHarvard University Press · USKuwait University · KWPeninsula College of Medicine and Dentistry · GBUniversity of Western Australia · AUYale University · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
Multiethnic Study of Type 2 Diabetes GenesU01DK085526 · NIDDK · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, JABLONSKI, KATHLEEN ANN · 2009 to 2014
$15.7M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD RiskR01HL113323 · NHLBI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI BLANGERO, JOHN, CURRAN, JOANNE E. · 2012 to 2016
$8.2M
GENETIC ANALYSIS OF COMMON DISEASES: AN EVALUATIONR01GM031575 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 1985 to 2016
$7.8M
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican AmericansU01DK085524 · NIDDK · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI BLANGERO, JOHN, DEFRONZO, RALPH A · 2009 to 2019
$5.9M
NIDDM SUSCEPTIBILITY GENES IN MEXICAN-AMERICANSR01DK047482 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEHMAN, DONNA M · 1993 to 2010
$5.4M
Identifying T2D Variants by DNA Sequencing in Multiethnic SamplesU01DK085584 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO, BOEHNKE, MICHAEL L · 2009 to 2013
$4.1M
GWAS for Sleep Apnea and Endothelial Function Among Mexican AmericansR01HL102830 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HANIS, CRAIG L · 2010 to 2013
$2.8M
Identifying variants causal for Type 2 Diabetes in Major human populationsU01DK085545 · NIDDK · UNIVERSITY OF OXFORD · PI CHAN, JULIANA CN, EBRAHIM, SHAH BRIAN · 2009 to 2013
$2.8M
Identification and Replication of Type 2 Diabetes Genes in Mexican AmericansU01DK085501 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HANIS, CRAIG L · 2009 to 2013
$2.7M
NHGRI NIH HHS T32 HG000040NHLBI NIH HHS R01 HL102830NHLBI NIH HHS R01 HL113323NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK047482NIDDK NIH HHS R01 DK053889NIDDK NIH HHS R01 DK073541NIDDK NIH HHS U01 DK057295NIDDK NIH HHS U01 DK062370NIDDK NIH HHS U01 DK085501NIDDK NIH HHS U01 DK085524NIDDK NIH HHS U01 DK085526NIDDK NIH HHS U01 DK085545NIDDK NIH HHS U01 DK085584NIGMS NIH HHS R01 GM031575
6 · The paper itself

Abstract

backgroundThe Genetic Analysis Workshops (GAW) are a forum for development, testing, and comparison of statistical genetic methods and software. Each contribution to the workshop includes an application to a specified data set. Here we describe the data distributed for GAW19, which focused on analysis of human genomic and transcriptomic data.

methodsGAW19 data were donated by the T2D-GENES Consortium and the San Antonio Family Heart Study and included whole genome and exome sequences for odd-numbered autosomes, measures of gene expression, systolic and diastolic blood pressures, and related covariates in two Mexican American samples. These two samples were a collection of 20 large families with whole genome sequence and transcriptomic data and a set of 1943 unrelated individuals with exome sequence. For each sample, simulated phenotypes were constructed based on the real sequence data. 'Functional' genes and variants for the simulations were chosen based on observed correlations between gene expression and blood pressure. The simulations focused primarily on additive genetic models but also included a genotype-by-medication interaction. A total of 245 genes were designated as 'functional' in the simulations with a few genes of large effect and most genes explaining < 1 % of the trait variation. An additional phenotype, Q1, was simulated to be correlated among related individuals, based on theoretical or empirical kinship matrices, but was not associated with any sequence variants. Two hundred replicates of the phenotypes were simulated. The GAW19 data are an expansion of the data used at GAW18, which included the family-based whole genome sequence, blood pressure, and simulated phenotypes, but not the gene expression data or the set of 1943 unrelated individuals with exome sequence.

Identifiers

PMID27980614
PMCPMC5133484
OpenAlexW2550899360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.